2009/03/10 by Tsung‐Ping Su, Teruo Hayashi, D. Bruce Vaupel · 6 citations
Biochemistry, Genetics and Molecular Biology · Neuroscience · #Pharmacological Receptor Mechanisms and Effects #Receptor Mechanisms and Signaling #Tryptophan and brain disorders
paper · doi:10.1126/scisignal.261pe12
openalex publication_date 2009/03/10 · openalex created_date 2016/06/24 · openalex updated_date 2026/07/31
N,N-dimethyltryptamine (DMT) is a hallucinogen found endogenously in human brain that is commonly recognized to target the 5-hydroxytryptamine 2A receptor or the trace amine-associated receptor to exert its psychedelic effect. DMT has been recently shown to bind sigma-1 receptors, which are ligand-regulated molecular chaperones whose function includes inhibiting various voltage-sensitive ion channels. Thus, it is possible that the psychedelic action of DMT might be mediated in part through sigma-1 receptors. Here, we present a hypothetical signaling scheme that might be triggered by the binding of DMT to sigma-1 receptors.